ISCO Stock DD International Stem Cell Corp. 07/21/2014 17:44:13

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Nucor Corporation, a key player in the steel industry, had its Buy rating reaffirmed by Citi, setting a price target of $240. This was no idle gesture; it came hand-in-hand with a revised earnings per share (EPS) estimate dropped to $1.38 from an earlier forecast of $1.76, aligning closely with Nucor’s own guidance that projected an EPS between $1.30 and $1.40 for the...

Understanding Stanley Druckenmiller's Investment Approach Billionaire investor and former hedge fund manager Stanley Druckenmiller is well known for his unique approach to investing. With a knack for macroeconomic analysis, he consistently predicts market movements by taking a top-down view. A Bold Move into Regional Banks Recently, Druckenmiller made headlines with his...

FFW Corporation Announces Quarterly Cash Dividend WABASH, Ind. — FFW Corporation (OTC PINK: FFWC), the parent company of Crossroads Bank, has recently announced a quarterly cash dividend of $0.31 per share for its common stock. This dividend will be payable soon, specifically on September 26, and it targets shareholders who are recorded as of September 12. Financial...

Alaris Equity Partners Completes Final Prospectus Filing CALGARY, Alberta — Alaris Equity Partners Income Trust, known as Alaris, has made a significant move in its financial strategy by filing a final short form prospectus in various provinces across Canada. This filing aligns with their previously announced offering to secure $100 million in 6.25% convertible...

Xtreme Fighting Championships Exciting Return to South America Recently, Xtreme Fighting Championships (XFC), backed by Xtreme One Entertainment, Inc. (OTC: XONI), confirmed its much-anticipated return to the vibrant landscape of South America. This marks a significant milestone for the organization, which previously hosted numerous thrilling events in the region....